Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved

Background Invasive papillary carcinoma is a rare type of invasive ductal carcinoma. Neoadjuvant endocrine therapy is now considered as an optional therapy for postmenopausal women with hormone receptor-positive breast cancers, including invasive papillary carcinoma.